Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India
· Delayed Price · Currency is INR 23.11
-1.89 (-7.56%)
At close: Mar 6, 2026
BOM:531015 Revenue
Venmax Drugs and Pharmaceuticals had revenue of 15.52M INR in the quarter ending December 31, 2025, with 679.27% growth. This brings the company's revenue in the last twelve months to 44.14M, up 830.42% year-over-year. In the fiscal year ending March 31, 2025, Venmax Drugs and Pharmaceuticals had annual revenue of 8.07M.
Revenue (ttm)
44.14M
Revenue Growth
+830.42%
P/S Ratio
4.33
Revenue / Employee
22.07M
Employees
2
Market Cap
190.99M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Supha Pharmachem | 5.27B |
| Ishita Drugs and Industries | 161.68M |
| Alfavision Overseas (India) | 13.30M |
| Link Pharma Chem | 272.89M |
| Crestchem | 266.14M |
| Vasundhara Rasayans | 315.86M |
| Bacil Pharma | 5.48M |
| Tyche Industries | 505.54M |